期刊文献+

MMP-9、TIMP-1水平与急性脑梗死关系的研究 被引量:5

Relationship Between Levels of Serum MMP-9,TIMP-1 and Acute Stage of Cerebral Infarction
原文传递
导出
摘要 目的探讨MMP-9、TIMP-1水平与脑梗死TOAST分型及预后的关系。方法收集急性脑梗死患者90例,按照TOAST分型分为CE、LAA、SA三组;对照组30例;采用ELISA法,测定发病24 h内、第5 d和第10 d的血清MMP-9、TIMP-1;对照组采清晨空腹血1次,测定血清MMP-9、TIMP-1含量。随访1个月,记录发病1个月时的BI(Barthal Index)来评价预后含量。结果发病后24 h内,TOAST各亚型血清MMP-9含量均升高,与对照组比较差异有统计学意义(P<0.05),其中,CE组和LAA组高于SA组(P<0.05);第14 d各组MMP-9含量均降至正常水平。发病后24 h内,TOAST各亚型血清TIMP-1含量亦均升高,与对照组比较差异有统计学意义(P<0.05),其中,CE组和LAA组高于SA组(P<0.05);第14 d各组TIMP-1含量均降至正常水平。预后较好者其发病24 h内血清MMP-9含量为(567.1±263.0)ng/ml,明显低于预后较差者,其MMP-9含量为(893.7±451.1)ng/ml,两者比较差异有统计学意义(P<0.05)。结论MMP-9作为生物活性指标,有助于急性脑梗死的分型,并为我们提供病变程度和预后的信息,同时也可以作为我们评定预后的指标之一。 Objective To study the relationship among the levels of serum MMP- 9, TIMP- 1 and the classification of TOAST and the significance in prognosis in patients with cerebral infarction. Methods Ninety patients with cerebral infarction were included in our study, while 30 healthy people served as the control group. According to TOAST, the patients were divided into three subtypes: CE, LAA, and SA. The serum specimens were gathered for MMP -- 9 and TIMP- 1 determination with ELISA on admission, at the 7^th and 14th days of onset. All patients were recorded Barthal index (BI) on the first month of onset. Results The serum level of MMP- 9 increased after cerebral infarction, and were significantly higher than that in the control group (P〈 0.05). MMP- 9 in CE and LAA groups was significantly higher than that in SA group (P〈 0.0.5). At the 14^th day MMP- 9 in all groups decreased to normal. The serum level of TIMP - 1 increased after cerebral infarction, and were significantly higher than that in the control group (P〈 0.0.5). TIMP- 1 in CE and LAA groups were significantly higher than that in SA group (P〈 0.05). At the 14th day TIMP- 1 in all groups decreased to normal. The serum level of MMP- 9 in the patientS with better prognosis (567. 1 ± 253.0 ng/ml) was significantly lower than that in the patients with poor prognosis (893.7 ± 451.1 ng/ml), there was a statistically significant difference between them (P〈0.05). Conclusions The level of serum MMP - 9 within 24 hours of onset can reflect the classification, and also can use as an independent indicator of prognosis.
出处 《实用预防医学》 CAS 2009年第6期1892-1894,共3页 Practical Preventive Medicine
关键词 脑梗死 MMP-9 TIMP-1 TOAST分型 Cerebral infarction MMP-9 TIMP- 1 Classification of TOAST
  • 相关文献

参考文献9

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33055
  • 2Manclal M,Mandal A,Das S,et al. Clinical implications of matrix Metal- loproteinases[ J ]. Mol Cell Biochem, 2003,252 ( 1 - 2) : 305. 被引量:1
  • 3Malemud cJ. Matrix metalloproteinases( MMPs)in health and disease:an overview[ J ]. Front Biosci, 2005,11 ( 1 ) : 1696. 被引量:1
  • 4Libhy P. Changing concepts of atherogenesis[ J ]. J Intern Med, 2000, 247(2) :349 - 358. 被引量:1
  • 5Rosenberg GA, Cunningham LA, Wallace J, et al. Immunohisto- chemistry of Matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP - 9 linked to stromelysin - 1 and microglia in cell cultures[ J ]. Brain Res, 2001,893 ( 1 ) : 104 - 112. 被引量:1
  • 6Chakaborti S, Mandal M,Das S, et al. Regulation of matrix metalloproteinases an overview[J]. Mol Cell Biochem,2003,253(1-2) :269. 被引量:1
  • 7Hamann GF. Unriddling the role of matrix metalloproteinases in human cerebral stroke[J]. Stroke,2003,34(1 ) ;40. 被引量:1
  • 8Dzwonek J, Rylski M, Kaczmarek L. Matrix Metedloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain [J]. FEBSLett, 2004,67( 1 ) : 129. 被引量:1
  • 9毛玲,查运红,梅元武.基质金属蛋白酶-9与脑缺血血脑屏障损伤的关系[J].国际神经病学神经外科学杂志,2006,33(1):96-98. 被引量:23

二级参考文献23

  • 1Mandal M, Mandal A, Das S, et al. Clinical implications of matrix metalloproteinases. Mol Cell Biochem, 2003, 252 ( 1-2 ) :305 -329. 被引量:1
  • 2Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci, 2006, 11(1): 1696-1701. 被引量:1
  • 3Castillo J, Leira R, Blanco M. Metalloproteinases and neurovascular injury. Neurologia, 2004, 19 ( 6 ) : 312 -320. 被引量:1
  • 4Hamacher S, Matern S, Roeb E. Extracellular matrix - from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases. Dtsch Meal Wochenschr, 2004, 129(38): 1976-1980. 被引量:1
  • 5Chakraborti S, Mandal M, Das S, et al. Regulation of matrix metalloproleinases: an overview, Mol Cell Biochem, 2003, 253(1-2) : 269-285. 被引量:1
  • 6Hsieh HL, Yen MH, Jou MJ, et al. Intracellular signalings underlying bradykinin-induced matrix metalloproteinase-9 expression in rat brain astrocyte-1. Cell Signal, 2004, 16 ( 10 ) : 1163-1176. 被引量:1
  • 7Chung TW, Lee YC, Kim CH. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential. FASEB J, 2004, 18(10): 1123-1125. 被引量:1
  • 8Ruhul Amin AR, Senga T, Oo ML, et al. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1 beta:a role for the dual signalling pathways, Akt and Erk. Genes Cells,2003, 8(6) : 515-523. 被引量:1
  • 9Kato Y, Lambert CA, Colige AC, et al. Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling. J Biol Chem, 2005, 280 (12):10938-10944. 被引量:1
  • 10Woo JH, Lim JH, Kim YH, et al. Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene,2004, 23(10): 1845-1853. 被引量:1

共引文献33076

同被引文献49

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部